Key Points
-
Through the production of cytokines, B cells influence multiple aspects of immunity. B cell-derived cytokines guide the development of lymphoid tissues, shape and promote effector and memory T cell responses and can also negatively regulate immune responses.
-
The roles of B cells in lymphoid organogenesis often depends on their production of lymphotoxin α1β2 (LTα1β2). B cells can drive tertiary lymphoid tissue formation independently of lymphoid tissue-inducer cells by producing LTα1β2.
-
Following tissue damage, B cells can produce cytokines that influence tissue regeneration and pathophysiology in non-immunological organs.
-
B cells can control the polarization of effector T cell responses and the formation of memory T cells through the provision of cytokines.
-
B cells can negatively regulate immune response by producing interleukin-10 (IL-10) and IL-35. Subsets of CD19+CD138hi 'regulatory plasma cells' are the major sources of these B cell-derived suppressive cytokines in vivo.
-
B cells from mice infected with helminth parasites can inhibit allergic inflammation through the production of IL-10.
Abstract
Cytokine production by B cells is important for multiple aspects of immunity. B cell-derived cytokines, including lymphotoxin, are essential for the ontogenesis, homeostasis and activation of secondary lymphoid organs, as well as for the development of tertiary lymphoid tissues at ectopic sites. Other B cell-derived cytokines, such as interleukin-6 (IL-6), interferon-γ and tumour necrosis factor, influence the development of effector and memory CD4+ T cell responses. Finally, B cells can regulate inflammatory immune responses, primarily through their provision of IL-10 and IL-35. This Review summarizes these various roles of cytokine-producing B cells in immunity and discusses the rational for targeting these cells in the clinic.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Manz, R. A., Hauser, A. E., Hiepe, F. & Radbruch, A. Maintenance of serum antibody levels. Annu. Rev. Immunol. 23, 367–386 (2005).
Dijkstra, C. D. & Dopp, E. A. Ontogenetic development of T- and B-lymphocytes and non-lymphoid cells in the white pulp of the rat spleen. Cell Tissue Res. 229, 351–363 (1983).
Endres, R. et al. Mature follicular dendritic cell networks depend on expression of lymphotoxin β receptor by radioresistant stromal cells and of lymphotoxin β and tumor necrosis factor by B cells. J. Exp. Med. 189, 159–168 (1999).
Fu, Y. X., Huang, G., Wang, Y. & Chaplin, D. D. B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin α-dependent fashion. J. Exp. Med. 187, 1009–1018 (1998).
Gonzalez, M., Mackay, F., Browning, J. L., Kosco-Vilbois, M. H. & Noelle, R. J. The sequential role of lymphotoxin and B cells in the development of splenic follicles. J. Exp. Med. 187, 997–1007 (1998).
Tumanov, A. et al. Distinct role of surface lymphotoxin expressed by B cells in the organization of secondary lymphoid tissues. Immunity 17, 239–250 (2002).
Ansel, K. M. et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406, 309–314 (2000).
Ngo, V. N., Cornall, R. J. & Cyster, J. G. Splenic T zone development is B cell dependent. J. Exp. Med. 194, 1649–1660 (2001).
Tumanov, A. V. et al. Cellular source and molecular form of TNF specify its distinct functions in organization of secondary lymphoid organs. Blood 116, 3456–3464 (2010).
Kumar, V. et al. Global lymphoid tissue remodeling during a viral infection is orchestrated by a B cell-lymphotoxin-dependent pathway. Blood 115, 4725–4733 (2010).
Scandella, E. et al. Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. Nat. Immunol. 9, 667–675 (2008).
Singh, K., Chang, C. & Gershwin, M. E. IgA deficiency and autoimmunity. Autoimmun. Rev. 13, 163–177 (2014).
Lorenz, R. G. & Newberry, R. D. Isolated lymphoid follicles can function as sites for induction of mucosal immune responses. Ann. NY Acad. Sci. 1029, 44–57 (2004).
Pabst, O. et al. Cryptopatches and isolated lymphoid follicles: dynamic lymphoid tissues dispensable for the generation of intraepithelial lymphocytes. Eur. J. Immunol. 35, 98–107 (2005).
McDonald, K. G., McDonough, J. S. & Newberry, R. D. Adaptive immune responses are dispensable for isolated lymphoid follicle formation: antigen-naive, lymphotoxin-sufficient B lymphocytes drive the formation of mature isolated lymphoid follicles. J. Immunol. 174, 5720–5728 (2005).
Bouskra, D. et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456, 507–510 (2008).
Pabst, O. et al. Adaptation of solitary intestinal lymphoid tissue in response to microbiota and chemokine receptor CCR7 signaling. J. Immunol. 177, 6824–6832 (2006).
Golovkina, T. V., Shlomchik, M., Hannum, L. & Chervonsky, A. Organogenic role of B lymphocytes in mucosal immunity. Science 286, 1965–1968 (1999).
Kerneis, S., Bogdanova, A., Kraehenbuhl, J. P. & Pringault, E. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science 277, 949–952 (1997).
Tumanov, A. V., Kuprash, D. V., Mach, J. A., Nedospasov, S. A. & Chervonsky, A. V. Lymphotoxin and TNF produced by B cells are dispensable for maintenance of the follicle-associated epithelium but are required for development of lymphoid follicles in the Peyer's patches. J. Immunol. 173, 86–91 (2004).
Fritz, J. H. et al. Acquisition of a multifunctional IgA+ plasma cell phenotype in the gut. Nature 481, 199–203 (2012). This paper demonstrates that plasma cells can combat pathogens in an antibody-independent manner through the production of soluble mediators.
Luther, S. A., Lopez, T., Bai, W., Hanahan, D. & Cyster, J. G. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 12, 471–481 (2000).
DiCosmo, B. F., Picarella, D. & Flavell, R. A. Local production of human IL-6 promotes insulitis but retards the onset of insulin-dependent diabetes mellitus in non-obese diabetic mice. Int. Immunol. 6, 1829–1837 (1994).
Campbell, I. L., Hobbs, M. V., Dockter, J., Oldstone, M. B. & Allison, J. Islet inflammation and hyperplasia induced by the pancreatic islet-specific overexpression of interleukin-6 in transgenic mice. Am. J. Pathol. 145, 157–166 (1994).
Eberl, G. et al. An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5, 64–73 (2004).
Lochner, M. et al. Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORγt and LTi cells. J. Exp. Med. 208, 125–134 (2011). This paper shows that B cells can drive the formation of tertiary lymphoid organs at inflamed sites in the absence of LTi cells.
Ammirante, M. et al. An IKKα–E2F1–BMI1 cascade activated by infiltrating B cells controls prostate regeneration and tumor recurrence. Genes Dev. 27, 1435–1440 (2013).
Ben-Neriah, Y. & Karin, M. Inflammation meets cancer, with NF-κB as the matchmaker. Nat. Immunol. 12, 715–723 (2011).
Ammirante, M., Luo, J. L., Grivennikov, S., Nedospasov, S. & Karin, M. B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature 464, 302–305 (2010). This paper demonstrates that cytokine production by B cells can influence prostate cancer relapse. Together with reference 27, it suggests that B cells might interact with tissue or cancer stem cells following tissue damage.
Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2012. CA Cancer J. Clin. 62, 10–29 (2012).
Gulley, J., Figg, W. D. & Dahut, W. L. Treatment options for androgen-independent prostate cancer. Clin. Adv. Hematol. Oncol. 1, 49–57 (2003).
Liu, Z. et al. Requirements for the development of IL-4-producing T cells during intestinal nematode infections: what it takes to make a Th2 cell in vivo. Immunol. Rev. 201, 57–74 (2004).
Leon, B. et al. Regulation of TH2 development by CXCR5+ dendritic cells and lymphotoxin-expressing B cells. Nat. Immunol. 13, 681–690 (2012).
Wojciechowski, W. et al. Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus. Immunity 30, 421–433 (2009). This paper reveals that IL-2 production by B cells influences the formation of memory CD4+ T cells.
Harris, D. P. et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 1, 475–482 (2000).
Riou, C. et al. Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells. J. Exp. Med. 204, 79–91 (2007).
Menard, L. C. et al. B cells amplify IFN-γ production by T cells via a TNF-α-mediated mechanism. J. Immunol. 179, 4857–4866 (2007).
Barr, T. A., Brown, S., Mastroeni, P. & Gray, D. TLR and B cell receptor signals to B cells differentially program primary and memory Th1 responses to Salmonella enterica. J. Immunol. 185, 2783–2789 (2010).
Bao, Y. et al. Identification of IFN-γ-producing innate B cells. Cell Res. 24, 161–176 (2014).
Ganapamo, F., Dennis, V. A. & Philipp, M. T. CD19+ cells produce IFN-γ in mice infected with Borrelia burgdorferi. Eur. J. Immunol. 31, 3460–3468 (2001).
Gjertsson, I., Foster, S. & Tarkowski, A. Polarization of cytokine responses in B- and T-lymphocytes during Staphylococcus aureus infection. Microb. Pathog. 35, 119–124 (2003).
Elkins, K. L., Leiby, D. A., Winegar, R. K., Nacy, C. A. & Fortier, A. H. Rapid generation of specific protective immunity to Francisella tularensis. Infect. Immun. 60, 4571–4577 (1992).
Elkins, K. L., Rhinehart-Jones, T., Nacy, C. A., Winegar, R. K. & Fortier, A. H. T-cell-independent resistance to infection and generation of immunity to Francisella tularensis. Infect. Immun. 61, 823–829 (1993).
Green, S. J. et al. Neutralization of gamma interferon and tumor necrosis factor alpha blocks in vivo synthesis of nitrogen oxides from l-arginine and protection against Francisella tularensis infection in Mycobacterium bovis BCG-treated mice. Infect. Immun. 61, 689–698 (1993).
Elkins, K. L., MacIntyre, A. T. & Rhinehart-Jones, T. R. Nonspecific early protective immunity in Francisella and Listeria infections can be dependent on lymphocytes. Infect. Immun. 66, 3467–3469 (1998).
Flaishon, L. et al. Autocrine secretion of interferon γ negatively regulates homing of immature B cells. J. Exp. Med. 192, 1381–1388 (2000).
Hart, G., Flaishon, L., Becker-Herman, S. & Shachar, I. Tight regulation of IFN-γ transcription and secretion in immature and mature B cells by the inhibitory MHC class I receptor, Ly49G2. J. Immunol. 175, 5034–5042 (2005).
Hart, G., Flaishon, L., Becker-Herman, S. & Shachar, I. Ly49D receptor expressed on immature B cells regulates their IFN-γ secretion, actin polymerization, and homing. J. Immunol. 171, 4630–4638 (2003).
Yoshimoto, T. et al. Induction of IgG2a class switching in B cells by IL-27. J. Immunol. 173, 2479–2485 (2004).
Yoshimoto, T., Okamura, H., Tagawa, Y. I., Iwakura, Y. & Nakanishi, K. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-γ production from activated B cells. Proc. Natl Acad. Sci. USA 94, 3948–3953 (1997).
Harris, D. P., Goodrich, S., Gerth, A. J., Peng, S. L. & Lund, F. E. Regulation of IFN-γ production by B effector 1 cells: essential roles for T-bet and the IFN-γ receptor. J. Immunol. 174, 6781–6790 (2005).
Kouskoff, V. et al. Antigens varying in affinity for the B cell receptor induce differential B lymphocyte responses. J. Exp. Med. 188, 1453–1464 (1998).
Hilgendorf, I. et al. Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity. Circulation 129, 1677–1687 (2014).
Curtiss, L. K. & Tobias, P. S. Emerging role of Toll-like receptors in atherosclerosis. J. Lipid Res. 50, S340–S345 (2009).
Weber, G. F. et al. Pleural innate response activator B cells protect against pneumonia via a GM-CSF–IgM axis. J. Exp. Med. 211, 1243–1256 (2014).
Rauch, P. J. et al. Innate response activator B cells protect against microbial sepsis. Science 335, 597–601 (2012).
Karnowski, A. et al. B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1. J. Exp. Med. 209, 2049–2064 (2012).
Barr, T. A. et al. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6- producing B cells. J. Exp. Med. 209, 1001–1010 (2012).
Molnarfi, N. et al. MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies. J. Exp. Med. 210, 2921–2937 (2013).
Bermejo, D. A. et al. Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells. Nat. Immunol. 14, 514–522 (2013). This paper shows that some microbial enzymes can induce polyclonal cytokine production by B cells without acting on classical innate immune receptors.
Tosello Boari, J. et al. IL-17RA signaling reduces inflammation and mortality during Trypanosoma cruzi infection by recruiting suppressive IL-10-producing neutrophils. PLoS Pathog. 8, e1002658 (2012).
Mizoguchi, A., Mizoguchi, E., Smith, R. N., Preffer, F. I. & Bhan, A. K. Suppressive role of B cells in chronic colitis of T cell receptor α mutant mice. J. Exp. Med. 186, 1749–1756 (1997).
Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R. S. & Bhan, A. K. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16, 219–230 (2002).
Mizoguchi, E., Mizoguchi, A., Preffer, F. I. & Bhan, A. K. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int. Immunol. 12, 597–605 (2000).
Colgan, S. P., Hershberg, R. M., Furuta, G. T. & Blumberg, R. S. Ligation of intestinal epithelial CD1d induces bioactive IL-10: critical role of the cytoplasmic tail in autocrine signaling. Proc. Natl Acad. Sci. USA 96, 13938–13943 (1999).
Shimomura, Y. et al. Regulatory role of B-1 B cells in chronic colitis. Int. Immunol. 20, 729–737 (2008).
Maseda, D. et al. Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-γ+CD4+ T cell numbers during colitis development in mice. J. Immunol. 191, 2780–2795 (2013).
van den Biggelaar, A. H. et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 356, 1723–1727 (2000).
Bach, J. F. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347, 911–920 (2002).
Yazdanbakhsh, M., Kremsner, P. G. & van Ree, R. Allergy, parasites, and the hygiene hypothesis. Science 296, 490–494 (2002).
Smits, H. H. et al. Protective effect of Schistosoma mansoni infection on allergic airway inflammation depends on the intensity and chronicity of infection. J. Allergy Clin. Immunol. 120, 932–940 (2007).
Mangan, N. E. et al. Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. J. Immunol. 173, 6346–6356 (2004).
van der Vlugt, L. E. et al. Schistosomes induce regulatory features in human and mouse CD1dhi B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells. PLoS ONE 7, e30883 (2012).
Amu, S. et al. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J. Allergy Clin. Immunol. 125, 1114–1124.e8 (2010).
Fillatreau, S., Gray, D. & Anderton, S. M. Not always the bad guys: B cells as regulators of autoimmune pathology. Nat. Rev. Immunol. 8, 391–397 (2008).
Wilson, M. S. et al. Helminth-induced CD19+CD23hi B cells modulate experimental allergic and autoimmune inflammation. Eur. J. Immunol. 40, 1682–1696 (2010).
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D. & Anderton, S. M. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3, 944–950 (2002).
Shen, P. et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507, 366–370 (2014). This paper identifies IL-35 secretion as a novel mechanism of B cell-mediated regulation and demonstrates that IL-10 and IL-35 are provided by distinct sets of regulatory plasma cells.
Lampropoulou, V. et al. TLR-activated B cells suppress T cell-mediated autoimmunity. J. Immunol. 180, 4763–4773 (2008).
Ochoa-Reparaz, J., Mielcarz, D. W., Haque-Begum, S. & Kasper, L. H. Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora. Gut Microbes 1, 103–108 (2010).
Rosser, E. C. et al. Regulatory B cells are induced by gut microbiota-driven interleukin-1β and interleukin-6 production. Nat. Med. 20, 1334–1339 (2014).
Mauri, C., Gray, D., Mushtaq, N. & Londei, M. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197, 489–501 (2003).
Lampropoulou, V. et al. Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity. Immunol. Rev. 233, 146–161 (2010).
Devergne, O., Birkenbach, M. & Kieff, E. Epstein–Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc. Natl Acad. Sci. USA 94, 12041–12046 (1997).
Collison, L. W. et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450, 566–569 (2007).
Niedbala, W. et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur. J. Immunol. 37, 3021–3029 (2007).
Yanaba, K. et al. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28, 639–650 (2008).
Candando, K. M., Lykken, J. M. & Tedder, T. F. B10 cell regulation of health and disease. Immunol. Rev. 259, 259–272 (2014).
Matsushita, T., Yanaba, K., Bouaziz, J. D., Fujimoto, M. & Tedder, T. F. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118, 3420–3430 (2008).
Rangaswamy, U. S. & Speck, S. H. Murine gammaherpesvirus M2 protein induction of IRF4 via the NFAT pathway leads to IL-10 expression in B cells. PLoS Pathog. 10, e1003858 (2014).
Matsumoto, M. et al. Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. Immunity 41, 1040–1051 (2014).
Cretney, E. et al. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat. Immunol. 12, 304–311 (2011).
Ries, S. et al. B-type suppression: a role played by “regulatory B cells” or “regulatory plasma cells”? Eur. J. Immunol. 44, 1251–1257 (2014).
Dang, V. D., Hilgenberg, E., Ries, S., Shen, P. & Fillatreau, S. From the regulatory functions of B cells to the identification of cytokine-producing plasma cell subsets. Curr. Opin. Immunol. 28, 77–83 (2014).
Jacobi, A. M. et al. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 48, 1332–1342 (2003).
Nath, S. K., Harley, J. B. & Lee, Y. H. Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis. Hum. Genet. 118, 225–234 (2005).
Gateva, V. et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet. 41, 1228–1233 (2009).
Llorente, L. et al. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum. 43, 1790–1800 (2000).
Xu, Y., Harder, K. W., Huntington, N. D., Hibbs, M. L. & Tarlinton, D. M. Lyn tyrosine kinase: accentuating the positive and the negative. Immunity 22, 9–18 (2005).
Scapini, P. et al. B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice. Proc. Natl Acad. Sci. USA 108, E823–E832 (2011).
Teichmann, L. L. et al. B cell-derived IL-10 does not regulate spontaneous systemic autoimmunity in MRL.Faslpr mice. J. Immunol. 188, 678–685 (2012).
Yin, Z. et al. IL-10 regulates murine lupus. J. Immunol. 169, 2148–2155 (2002).
Blair, P. A. et al. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J. Immunol. 182, 3492–3502 (2009).
Neves, P. et al. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 33, 777–790 (2010). This paper demonstrates for the first time that IL-10-producing CD19+CD138hi regulatory plasma cells regulate innate and T cell immune responses.
Lee, C. C. & Kung, J. T. Marginal zone B cell is a major source of Il-10 in Listeria monocytogenes susceptibility. J. Immunol. 189, 3319–3327 (2012).
Tanigaki, K. et al. Notch–RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat. Immunol. 3, 443–450 (2002).
Duddy, M. et al. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J. Immunol. 178, 6092–6099 (2007).
Hirotani, M. et al. Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis. J. Neuroimmunol. 221, 95–100 (2010).
Correale, J., Farez, M. & Razzitte, G. Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann. Neurol. 64, 187–199 (2008).
Bar-Or, A. et al. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS? Ann. Neurol. 67, 452–461 (2010).
Bar-Or, A. et al. Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, Phase I trial. Ann. Neurol. 63, 395–400 (2008).
Hauser, S. L. et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358, 676–688 (2008).
Goetz, M., Atreya, R., Ghalibafian, M., Galle, P. R. & Neurath, M. F. Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm. Bowel Dis. 13, 1365–1368 (2007).
Dorner, T., Radbruch, A. & Burmester, G. R. B-cell-directed therapies for autoimmune disease. Nat. Rev. Rheumatol. 5, 433–441 (2009).
Balazs, M., Martin, F., Zhou, T. & Kearney, J. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17, 341–352 (2002).
O'Connor, B. P. et al. BCMA is essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med. 199, 91–98 (2004).
Hartung, H. P. & Kieseier, B. C. Atacicept: targeting B cells in multiple sclerosis. Ther. Adv. Neurol Disord. 3, 205–216 (2010).
Larousserie, F. et al. Variable expression of Epstein–Barr virus-induced gene 3 during normal B-cell differentiation and among B-cell lymphomas. J. Pathol. 209, 360–368 (2006).
Heine, G. et al. Autocrine IL-10 promotes human B-cell differentiation into IgM- or IgG-secreting plasmablasts. Eur. J. Immunol. 44, 1615–1621 (2014).
Miles, K. et al. A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells. Proc. Natl Acad. Sci. USA 109, 887–892 (2012).
Miyazaki, Y. et al. A novel microRNA-132–surtuin-1 axis underlies aberrant B-cell cytokine regulation in patients with relapsing-remitting multiple sclerosis. PLoS ONE 9, e105421 (2014). This paper identifies a molecular mechanism underlying some of the defects in cytokine production by B cells in multiple sclerosis.
Acknowledgements
The laboratory of S.F. is supported by grants from the Deutsche Forschungsgemeinschaft (SFB-650, TRR-130 and FI-1238/02), Hertie Stiftung, the ERA-NET Anti-bacterial Immune Regulation (ABIR) grant and an advanced grant from the Merieux Institute.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Shen, P., Fillatreau, S. Antibody-independent functions of B cells: a focus on cytokines. Nat Rev Immunol 15, 441–451 (2015). https://doi.org/10.1038/nri3857
Published:
Issue Date:
DOI: https://doi.org/10.1038/nri3857
This article is cited by
-
Identification of a novel immune-related transcriptional regulatory network in sarcopenia
BMC Geriatrics (2023)
-
Clinical prognostic value of OSGIN2 in gastric cancer and its proliferative effect in vitro
Scientific Reports (2023)
-
Immune subset-committed proliferating cells populate the human foetal intestine throughout the second trimester of gestation
Nature Communications (2023)
-
A Pilot Study to Develop Paraneoplastic Cerebellar Degeneration Mouse Model
The Cerebellum (2023)
-
Immunology and immunotherapy in gastric cancer
Clinical and Experimental Medicine (2023)
